Agilent Technologies, Inc.

NYSE:A 주식 보고서

시가총액: US$38.7b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Agilent Technologies 미래 성장

Future 기준 확인 2/6

Agilent Technologies (는) 각각 연간 7.5% 및 5.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 8.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 24.8% 로 예상됩니다.

주요 정보

7.5%

수익 성장률

8.5%

EPS 성장률

Life Sciences 수익 성장16.7%
매출 성장률5.1%
향후 자기자본 수익률24.8%
애널리스트 커버리지

Good

마지막 업데이트10 Jun 2024

최근 미래 성장 업데이트

Recent updates

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22
Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07
Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Dec 07
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Oct 26
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Sep 08
Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Aug 21
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Jul 23
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Jul 10
Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

May 28
What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

Agilent Technologies Stock: Starting To Look Appealing

May 25

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely

Apr 17
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely

Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Apr 03
Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Mar 21
Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment

Mar 09
Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment

Agilent Technologies declares $0.225 dividend

Feb 22

Fluor's unit gets contract to expand Agilent's manufacturing facility in Colorado

Feb 16

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Jan 30
Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold

Jan 16

Agilent to acquire Avida for cancer research

Jan 04

Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet

Dec 30
Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet

Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati

Dec 13

수익 및 매출 성장 예측

NYSE:A - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
10/31/20267,3191,5491,7302,04813
10/31/20256,8451,4251,5461,87417
10/31/20246,4601,3101,3331,70416
4/30/20246,5911,2421,5381,896N/A
1/31/20246,7351,2361,6491,961N/A
10/31/20236,8331,2401,4741,772N/A
7/31/20236,9941,1331,4201,704N/A
4/30/20237,0401,3511,1831,468N/A
1/31/20236,9301,3231,0611,353N/A
10/31/20226,8481,2541,0211,312N/A
7/31/20226,6591,3281,0221,305N/A
4/30/20226,5271,2631,0581,313N/A
1/31/20226,4451,2051,2801,502N/A
10/31/20216,3191,2101,2971,485N/A
7/31/20216,1429901,2681,421N/A
4/30/20215,8179251,2531,377N/A
1/31/20215,5308101,0921,218N/A
10/31/20205,339719802921N/A
7/31/20205,223691736858N/A
4/30/20205,236683665810N/A
1/31/20205,236764598749N/A
10/31/20195,1631,0718651,021N/A
7/31/20195,0901,0729171,079N/A
4/30/20195,0191,1178871,034N/A
1/31/20194,9871,1409291,085N/A
10/31/20184,9143169101,087N/A
7/31/20184,8092988041,003N/A
4/30/20184,7202378251,034N/A
1/31/20184,616196N/A988N/A
10/31/20174,472684N/A889N/A
7/31/20174,394633N/A835N/A
4/30/20174,324582N/A801N/A
1/31/20174,241509N/A798N/A
10/31/20164,202462N/A793N/A
7/31/20164,126476N/A800N/A
4/30/20164,096465N/A714N/A
1/31/20164,040466N/A643N/A
10/31/20154,038438N/A1,322N/A
7/31/20154,046306N/A1,245N/A
4/30/20154,041256N/A1,165N/A
1/31/20154,066204N/A1,307N/A
10/31/20144,048232N/A731N/A
7/31/20144,723435N/A924N/A
4/30/20145,366540N/A1,111N/A
1/31/20146,110666N/A1,101N/A
10/31/20133,894225N/A1,152N/A
7/31/20136,831938N/A1,260N/A

애널리스트 미래 성장 예측

수입 대 저축률: A 의 연간 예상 수익 증가율( 7.5% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: A 의 연간 수익( 7.5% ) US 시장( 14.9% 보다 느리게 성장할 것으로 예상됩니다. 14.9% 연간).

고성장 수익: A 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: A 의 수익(연간 5.1% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: A 의 수익(연간 5.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: A 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 24.8 %)


성장 기업 발견